Comstock Capital Value Fund Q2 2025 Commentary (undefined:CPCRX)

Core Insights - Blueprint Medicines Corporation is a pharmaceutical company that focuses on developing medicines for genomically defined cancers [2] Group 1 - The company represented 5.3% of net assets as of June 30, 2025 [2]